3-methoxytyramine has been researched along with Minimal Disease, Residual in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lam, L | 1 |
| Woollard, GA | 1 |
| Teague, L | 1 |
| Davidson, JS | 1 |
1 other study available for 3-methoxytyramine and Minimal Disease, Residual
| Article | Year |
|---|---|
Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
Topics: Biomarkers, Tumor; Case-Control Studies; Child; Child, Preschool; Chromatography, High Pressure Liqu | 2017 |